<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">233</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2024.5.3.39-46</article-id>
<title-group><article-title>Antibiotic classification, mechanisms, and indications: A review</article-title></title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Haddad</surname><given-names>Mohammed F</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Abdullah</surname><given-names>Basima A</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>AlObeidi</surname><given-names>Hassan AA</given-names></name><xref ref-type="aff" rid="aff3"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Saadi</surname><given-names>Ali M</given-names></name><xref ref-type="aff" rid="aff4"/></contrib>
<contrib contrib-type="author"><name><surname>Haddad</surname><given-names>Mustafa F</given-names></name></contrib>
<aff id="aff1"><label>1</label>Medical Laboratory Techniques Department / Mosul Medical Technical Institute / Northern Technical University/ Mosul/ Iraq</aff>
<aff id="aff2"><label>2</label>Dept. of Biology /College of Science/University of Mosul/ Mosul/ Iraq</aff>
<aff id="aff3"><label>3</label>M.Sc. Bacteriology, Mosul General Hospital, Mosul Iraq Department of Anesthesia, Iraq</aff>
<aff id="aff4"><label>4</label>Techniques, Mosul Medical Technical Institute, Northern Technical University, Mosul, Iraq</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2024</year></pub-date>
<volume>5</volume>
<issue>3</issue>
<fpage>39</fpage>
<lpage>46</lpage>
<history>
<date date-type="received"><day>02</day><month>06</month><year>2024</year></date>
<date date-type="accepted"><day>07</day><month>07</month><year>2024</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/233/antibiotic-classification-mechanisms-and-indications-a-review"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/233/download"/>
<abstract><p>An antibiotic was originally a material created by one microorganism that selectively inhibits another’s development. Since then, synthetic antibiotics have been developed that perform comparable tasks, typically chemically similar to natural antibiotics. There are no effects of antibiotics on viral infections. Antibiotics are used to treat bacterial infections in humans and animals. Several proposed classifications of antibiotics including chemical structure, mode of action, or organism of inhibitory activity. Most of the classification systems include two primary categories, the first categorizing based on chemical structure and the second categorizing based on the mechanism of action. Depending on their action, antibiotics are classified into bactericidal or bacteriostatic agents. Bactericidal agents kill or destroy the bacteria in the infected tissue; examples of bactericidal agents include penicillin, cephalosporins, fluoroquinolones, and aminoglycosides. Bacteriostatic agents cease bacterial multiplication, allowing other mechanisms of the immune system to kill the microbes. The antibacterial actions of antibiotics include inhibiting the bacterial cell wall, interrupting protein synthesis, plowing down the bacterial nucleic acid (DNA/RNA), inhibiting the biochemical metabolism, chelating metallic cations that are necessary for bacterial growth, and impairing the bacterial membranes by disintegrating it.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>antibiotic</kwd><kwd>penicillin</kwd><kwd>carbapenem</kwd><kwd>LPS</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Abushaheen MA, Fatani AJ, Alosaimi M, Mansy W, George M, Acharya S, Jhugroo P. Antimicrobial resistance, mechanisms and its clinical significance. Disease-a-Month. 2020;66(6):100971. Available from: academia.edu</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Acharya PC, Kurosu M. Medicinal chemistry of chemotherapeutic agents: a comprehensive resource of anti-infective and anti-cancer drugs; c2023. [HTML]</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Adaji JA, Akaba GO, Isah AY, Yunusa T. Short versus long-term antibiotic prophylaxis in cesarean section: a randomized clinical trial. Nigerian Medical Journal. 2020. Available from: ajol.info; c2020.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Aguirre Rivera J, Larsson J, Volkov IL, Seefeldt AC, Sanyal S, Johansson M. Real-time measurements of aminoglycoside effects on protein synthesis in live cells. Proceedings of the National Academy of Sciences; 2021:118(9). Available from: pnas.org International Journal of Medical and All Body Health Research www.allmedicaljournal.com</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Ahmadi MH. Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis. Antimicrobial Resistance &amp; Infection Control. 2021. Available from: springer.com</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Alavi M, Hamblin MR. Antibacterial silver nanoparticles: effects on bacterial nucleic acids. Cellular, Molecular and Biomedical Reports. 2023;3(1):35-40. Available from: cmbr-journal.com</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Anandabaskar N. Protein synthesis inhibitors. In: Introduction to Basics of Pharmacology and Toxicology: Volume 2: Essentials of Systemic Pharmacology: From Principles to Practice. 2021. p. 835-868. [HTML]</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Arguedas A, Trzciński K, O’Brien KL, Ferreira DM, Wyllie AL, Weinberger D, Gessner BD. Upper respiratory tract colonization with Streptococcus pneumoniae in adults. Expert Review of Vaccines. 2020;19(4):353-366. Available from: lstmed.ac.uk</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Baquero F, Levin BR. Proximate and ultimate causes of the bactericidal action of antibiotics. Nature Reviews Microbiology. 2021. Available from: nature.com</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Bessa G. Bacterial infections. In: Dermatology in Public Health Environments: A Comprehensive Textbook. Cham: Springer International Publishing; 2023. p. 183-202. [HTML]</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Bhattacharjee MK. Antibiotics that inhibit cell wall synthesis. In: Chemistry of Antibiotics and Related Drugs. 2022. [HTML]</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Bu Y, Hu Q, Bao T, Xie X, Wang S. Recent advances in cell membrane-coated technology for drug discovery from natural products. TrAC Trends in Analytical Chemistry. 2022. [HTML]</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Cook MA, Wright GD. The past, present, and future of antibiotics. Science Translational Medicine. 2022. [HTML]</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. Urinary tract infection in women. Menopause Review/Przegląd Menopauzalny. 2021;20(1):40-47. Available from: termedia.pl</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Dighe SN, Collet TA. Recent advances in DNA gyrase-targeted antimicrobial agents. European Journal of Medicinal Chemistry. 2020. [HTML]</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Dutta D, Kaushik A, Kumar D, Bag S. Foodborne pathogenic vibrios: antimicrobial resistance. Frontiers in Microbiology. 2021. Available from: frontiersin.org</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Feldman C, Anderson R. The role of Streptococcus pneumoniae in community-acquired pneumonia. In: Seminars in Respiratory and Critical Care Medicine. Thieme Medical Publishers; 2020. 41(4):455-469. Available from: up.ac.za</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Frei A, Verderosa AD, Elliott AG, Zuegg J, Blaskovich MA. Metals to combat antimicrobial resistance. Nature Reviews Chemistry. 2023;7(3):202-224. Available from: nature.com</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Gallagher JC, MacDougall C. Antibiotics Simplified. 2022. Available from: jbpub.com</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Giovannoni M, Gramegna G, Benedetti M, Mattei B. Industrial use of cell wall degrading enzymes: the fine line between production strategy and economic feasibility. Frontiers in Bioengineering and Biotechnology. 2020;8:356. Available from: frontiersin.org</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Graham NC. A broad spectrum of opportunities− the history of the Bayer company and the evolution of antibiotics 1945−1990. 2023. Available from: uio.no</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Greydanus DE, Cates KW, Sadigh N. Pelvic inflammatory disease. In: Sexually Transmitted Infections in Adolescence and Young Adulthood: A Practical Guide for Clinicians. 2020. p. 69-86. [HTML]</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Grishin AV, Karyagina AS, Vasina DV, Vasina IV, Gushchin VA, Lunin VG. Resistance to peptidoglycan-degrading enzymes. Critical Reviews in Microbiology. 2020;46(6):703-726. [HTML]</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. 2021. Available from: google.com</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>World Health Organization. WHO operational handbook on tuberculosis. Module 4: treatment-drug-susceptible tuberculosis treatment. 2021. Available from: google.com</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Horváth A, Dobay O, Sahin-Tóth J, Juhász E, Pongrácz J, Iván M, Kristóf K. Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study. Annals of Clinical Microbiology and Antimicrobials. 2020;19:1-11. Available from: springer.com</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Iturriza-Gómara M, Cunliffe NA. Viral gastroenteritis. In: Hunter&apos;s Tropical Medicine and Emerging Infectious Diseases. Elsevier; 2020. p. 289-307. [HTML]</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Kim D, Kim S, Kwon Y, Kim Y, Park H, Kwak K, Kang LW. Structural insights for β-lactam antibiotics. Biomolecules &amp; Therapeutics. 2023;31(2):141. Available from: nih.gov</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Kirsch SH, Haeckl FPJ, Müller R. Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi. Natural Product Reports. 2022. [HTML]</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Klein EY, Milkowska-Shibata M, Tseng KK, Sharland M, Gandra S, Pulcini C, Laxminarayan R. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. The Lancet Infectious Diseases. 2021;21(1):107-115. Available from: sgul.ac.uk</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Konwar M, Gogtay NJ, Ravi R, Thatte UM, Bose D. Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women–a systematic review and meta-analysis. Journal of Chemotherapy. 2022;34(3):139-148. [HTML]</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>Lade H, Kim JS. Bacterial targets of antibiotics in Methicillin-Resistant Staphylococcus aureus. Antibiotics. 2021. Available from: mdpi.com</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>Lalchhandama K. History of penicillin. WikiJournal of Medicine. 2021. Available from: informit.org</mixed-citation></ref>
<ref id="R34"><label>34</label><mixed-citation>Li ZJ, Zhang HY, Ren LL, Lu QB, Ren X, Zhang CH, Yang WZ. Etiological and epidemiological features of acute respiratory infections in China. Nature Communications. 2021;12(1):5026. Available from: nature.com</mixed-citation></ref>
<ref id="R35"><label>35</label><mixed-citation>Lima LM, da Silva BNM, Barbosa G, Barreiro EJ. β-lactam antibiotics: an overview from a medicinal chemistry perspective. European Journal of Medicinal Chemistry. 2020;208:112829. [HTML]</mixed-citation></ref>
<ref id="R36"><label>36</label><mixed-citation>MacInnes JI, Van Immerseel F, Boyce JD, Rycroft AN, Vázquez-Boland JA. Pathogenesis of bacterial infections in animals. In: Prescott JF, editor. John Wiley &amp; Sons, Incorporated; 2022. [HTML]</mixed-citation></ref>
<ref id="R37"><label>37</label><mixed-citation>Mohammed SO, Shuaibu SDA, Gaya SA, Rabiu A. The International Journal of Medical and All Body Health Research www.allmedicaljournal.com efficacy of two doses versus 7 days’ course of prophylactic antibiotics following cesarean section: an experience from Aminu Kano Teaching Hospital. Annals of African Medicine. 2020;19(2):103-112. Available from: lww.com</mixed-citation></ref>
<ref id="R38"><label>38</label><mixed-citation>Nguyen NV, Do NTT, Nguyen CTK, Tran TK, Ho PD, Nguyen HH, Lewycka S. Community-level consumption of antibiotics according to the AWaRe (Access, Watch, Reserve) classification in rural Vietnam. JAC-Antimicrobial Resistance. 2020;2(3). Available from: oup.com</mixed-citation></ref>
<ref id="R39"><label>39</label><mixed-citation>Oliveira I, Rego C, Semedo G, Gomes D, Figueiras A, Roque F, Herdeiro MT. A systematic review on the impact of guidelines adherence on antibiotic prescription in respiratory infections. Antibiotics. 2020;9(9):546. Available from: mdpi.com</mixed-citation></ref>
<ref id="R40"><label>40</label><mixed-citation>Peloquin CA, Davies GR. The treatment of tuberculosis. Clinical Pharmacology &amp; Therapeutics. 2021;110(6):1455-1466. Available from: researchgate.net</mixed-citation></ref>
<ref id="R41"><label>41</label><mixed-citation>Prasad R, Singh A, Gupta N. Adverse drug reactions with first-line and second-line drugs in treatment of tuberculosis. Annals of the National Academy of Medical Sciences (India). 2021;57(01):15-35. Available from: thieme-connect.com</mixed-citation></ref>
<ref id="R42"><label>42</label><mixed-citation>Ramachanderan R, Schaefer B. Tetracycline antibiotics. ChemTexts. 2021. Available from: springer.com</mixed-citation></ref>
<ref id="R43"><label>43</label><mixed-citation>Rao CD. Enteroviruses in gastrointestinal diseases. Reviews in Medical Virology. 2021. [HTML]</mixed-citation></ref>
<ref id="R44"><label>44</label><mixed-citation>Riu F, Ruda A, Ibba R, Sestito S, Lupinu I, Piras S, Carta A. Antibiotics and carbohydrate-containing drugs targeting bacterial cell envelopes: an overview. Pharmaceuticals. 2022;15(8):942. Available from: mdpi.com</mixed-citation></ref>
<ref id="R45"><label>45</label><mixed-citation>Rohs PDA, Bernhardt TG. Growth and division of the peptidoglycan matrix. Annual Review of Microbiology. 2021. [HTML]</mixed-citation></ref>
<ref id="R46"><label>46</label><mixed-citation>Sahoo BM, Banik BK. Therapeutic potentials of β‐ lactam: a scaffold for new drug development. In: Synthetic Approaches to Nonaromatic Nitrogen Heterocycles. 2020. p. 59-88. Available from: researchgate.net</mixed-citation></ref>
<ref id="R47"><label>47</label><mixed-citation>Satoskar RS, Bhandarkar SD. Pharmacology and Pharmacotherapeutics. 2020. [HTML]</mixed-citation></ref>
<ref id="R48"><label>48</label><mixed-citation>Singhal M, Agrawal M, Bhavna K, Sethiya NK, Bhargava S, Gondkar KS, Arora MK. Chloramphenicol and tetracycline (broad spectrum antibiotics). In: Antibiotics-Therapeutic Spectrum and Limitations. Academic Press; 2023. p. 155-165. [HTML]</mixed-citation></ref>
<ref id="R49"><label>49</label><mixed-citation>Spencer AC, Panda SS. DNA gyrase as a target for quinolones. Biomedicines. 2023. Available from: mdpi.com</mixed-citation></ref>
<ref id="R50"><label>50</label><mixed-citation>Szlasa W, Zendran I, Zalesińska A, Tarek M, Kulbacka J. Lipid composition of the cancer cell membrane. Journal of Bioenergetics and Biomembranes. 2020;52(5):321-342. Available from: springer.com</mixed-citation></ref>
<ref id="R51"><label>51</label><mixed-citation>Tietel M, Shema-Didi L, Roth R, Wolf MF, Bornstein J. Compliance with a new quality standard regarding administration of prophylactic antibiotics before cesarean section. The Journal of Maternal-Fetal &amp; Neonatal Medicine. 2022;35(25):6243-6249. [HTML]</mixed-citation></ref>
<ref id="R52"><label>52</label><mixed-citation>Tutone M, Johansen TEB, Cai T, Mushtaq S, Livermore DM. Susceptibility and resistance to fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study. International Journal of Antimicrobial Agents. 2022;59(5):106574. Available from: sciencedirect.com</mixed-citation></ref>
<ref id="R53"><label>53</label><mixed-citation>Uddin TM, Chakraborty AJ, Khusro A, Zidan BRM, Mitra S, Emran TB, Koirala N. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. Journal of Infection and Public Health. 2021;14(12):1750-1766. Available from: sciencedirect.com</mixed-citation></ref>
<ref id="R54"><label>54</label><mixed-citation>Urban-Chmiel R, Marek A, Stępień-Pyśniak D, Wieczorek K, Dec M, Nowaczek A, Osek J. Antibiotic resistance in bacteria—A review. Antibiotics. 2022;11(8):1079. Available from: mdpi.com</mixed-citation></ref>
<ref id="R55"><label>55</label><mixed-citation>Varela MF, Stephen J, Lekshmi M, Ojha M, Wenzel N, Sanford LM, Kumar SH. Bacterial resistance to antimicrobial agents. Antibiotics. 2021;10(5):593. Available from: mdpi.com</mixed-citation></ref>
<ref id="R56"><label>56</label><mixed-citation>Wang Z. The Chemistry and Biology of Beta-Lactams. 2023. [HTML]</mixed-citation></ref>
<ref id="R57"><label>57</label><mixed-citation>Wang Z, Sun Q, Zhang H, Wang J, Fu Q, Qiao H, Wang Q. Insight into antibacterial mechanism of polysaccharides: a review. LWT. 2021;150:111929. [HTML]</mixed-citation></ref>
<ref id="R58"><label>58</label><mixed-citation>Wilson DN, Hauryliuk V, Atkinson GC, O’Neill AJ. Target protection as a key antibiotic resistance mechanism. Nature Reviews Microbiology. 2020;18(11):637-648. Available from: whiterose.ac.uk</mixed-citation></ref>
<ref id="R59"><label>59</label><mixed-citation>Workowski KA. Sexually transmitted infections treatment guidelines, 2021. MMWR. Recommendations and Reports. 2021. Available from: cdc.gov</mixed-citation></ref>
<ref id="R60"><label>60</label><mixed-citation>Yueh CM, Chi H, Chiu NC, Huang FY, Huang DTN, Chang L, Huang CY. Etiology, clinical features, management, and outcomes of skin and soft tissue infections in hospitalized children: a 10-year review. Journal of Microbiology, Immunology and Infection. 2022;55(4):728-739. Available from: sciencedirect.com</mixed-citation></ref>
<ref id="R61"><label>61</label><mixed-citation>Zhang F, Cheng W. The mechanism of bacterial resistance and potential bacteriostatic strategies. Antibiotics. 2022. Available from: mdpi.com</mixed-citation></ref>
<ref id="R62"><label>62</label><mixed-citation>Zheng Y, Zhu X, Jiang M, Cao F, You Q, Chen X. Development and applications of D‐amino acid derivatives‐based metabolic labeling of bacterial peptidoglycan. Angewandte Chemie. 2024;136(17). [HTML] Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</mixed-citation></ref>
</ref-list></back>
</article>